Compare Amphastar Pharmaceuticals Inc (AMPH) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Sana Biotechnology Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Sana Biotechnology Inc trades at $3.78 (market cap $1.13B). The key difference: Sana Biotechnology Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| AMPH | SANA | |
|---|---|---|
Market Cap | $868.62M | $1.13B |
Sector | Health | Health |
52-Week High | $30.81 | $5.92 |
52-Week Low | $16.87 | $2.68 |
Enterprise Value | $1.27B | $1.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
